Abbott announces that it has received premarket approval (PMA) from the FDA for its ARCHITECT CORE automated hepatitis B test, to be used on its ARCHITECT i 2000 and i 2000SR immunoassay testing instruments.
Read MoreAdvanDx today announced it received FDA 510(k) clearance for GBS PNA FISH for detection of Streptococcus agalactiae, aka Group B Strep, from turbid Lim Broths inoculated with vaginal and rectal swabs obtained from pregnant women between 35 and 37 weeks gestation.
Read MoreChembio Diagnostic Systems and the Infectious Disease Research Institute (IDRI) announce an agreement for Chembio to use its dual path platform technology to develop and manufacture a device for the diagnosis of visceral leishmaniasis.
Read More
AMS Diagnostics LLC, Beckman Coulter Inc, Olympus America Inc, Ortho Clinical Diagnostics, Randox Laboratories Ltd, Siemens, Tosoh Bioscience Inc
Read MoreClarient Inc announced the commercial launch of a new breast cancer test that helps physicians identify the probability of a patient’s cancer recurring and assess the need for chemotherapy.
Read More